Table 1.

Demographic and Clinical Data for the Participants in Cohort 1

	SZ	MDD	BD	Control	Statistics
Number (male/female)	17 (8/9)	9 (3/6)	6 (1/5)	19 (10/9)	P=.41 a
Age, years (mean±SD)	33.6±15.7	39.1±10.2	41.8±13.3	36.1±12.9	P=.57 b
Duration of illness, years (mean±SD) c	9.1±13.7	4.8±2.9	7.8±6.3	N.A.	P =.81 b
HAMD-21, score (mean±SD)	N.A.	11.2±8.5	14.4±5.9	N.A.	N.A
PANSS positive, score (mean±SD) d	21.4±5.4	N.A.	N.A.	N.A.	N.A.
PANSS negative, score (mean±SD) d	22.4±6.4	N.A.	N.A.	N.A.	N.A.
PANSS general pathology, score (mean±SD) d	47.3±11.4	N.A.	N.A.	N.A.	N.A.
YMRS, score (mean±SD)	N.A.	N.A.	6.3±4.0	N.A.	N.A.

Abbreviations: BD, bipolar disorder; HAMD-21, 21-item Hamilton Depression Rating Scale; MDD, major depressive disorder; N.A., not applicable; PANSS, Positive and Negative Symptom Scale; SZ, schizophrenia; YMRS, Young Mania Rating Scale.

^aChi-squared test.

^bANOVA.

^cMissing data for 5 individuals in the MDD patient group and 1 individual in the BD patient group.

^dMissing data for 4 individuals in the SZ patient group.